Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.

LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
CYANOKIT | SERB S.A. | Actual shortage | 5G | Updated Report | 2025-03-24 | 253207 |
NRA-URSODIOL | NORA PHARMA INC | Actual shortage | 250MG | Updated Report | 2025-03-24 | 248677 |
NRA-URSODIOL | NORA PHARMA INC | Actual shortage | 500MG | Updated Report | 2025-03-24 | 248680 |
NRA-BETAHISTINE | NORA PHARMA INC | Actual shortage | 8MG | Updated Report | 2025-03-24 | 248494 |
EPINEPHRINE INJECTION USP | HIKMA CANADA LIMITED | Anticipated shortage | 1MG | New Report | 2025-03-24 | 253333 |
TESTOSTERONE ENANTHATE INJECTION, USP | HIKMA CANADA LIMITED | Actual shortage | 200MG | Updated Report | 2025-03-24 | 249532 |
JAMP-LOSARTAN | JAMP PHARMA CORPORATION | Actual shortage | 50MG | Updated Report | 2025-03-24 | 221985 |
SOFRACORT | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 0.05MG 0.5MG 5MG | Updated Report | 2025-03-24 | 242064 |
ONE-ALPHA | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 2MCG | Updated Report | 2025-03-24 | 247425 |
RYTHMODAN | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 100MG | Updated Report | 2025-03-24 | 248525 |
SUFENTANIL CITRATE INJECTION USP | SANDOZ CANADA INCORPORATED | Anticipated shortage | 50MCG | New Report | 2025-03-24 | 253320 |
SANDOZ APIXABAN SDZ | SANDOZ CANADA INCORPORATED | Anticipated shortage | 2.5MG | New Report | 2025-03-24 | 253317 |
PMS-RIZATRIPTAN RDT | PHARMASCIENCE INC | Resolved | 10MG | Updated Report | 2025-03-24 | 249580 |
ZOLEDRONIC ACID - Z | SANDOZ CANADA INCORPORATED | Actual shortage | 4MG | Updated Report | 2025-03-24 | 252244 |
PMS-QUINAPRIL | PHARMASCIENCE INC | Actual shortage | 40MG | Updated Report | 2025-03-24 | 237391 |
SANDOZ TOLTERODINE LA | SANDOZ CANADA INCORPORATED | Actual shortage | 2MG | Updated Report | 2025-03-24 | 242762 |
TIMOLOL MALEATE-EX | SANDOZ CANADA INCORPORATED | Actual shortage | 0.5% | Updated Report | 2025-03-24 | 235074 |
PRAXIS ASA EC 81 MG DAILY LOW DOSE | PHARMASCIENCE INC | Actual shortage | 81MG | Updated Report | 2025-03-24 | 250559 |
TIMOLOL MALEATE-EX | SANDOZ CANADA INCORPORATED | Actual shortage | 0.25% | Updated Report | 2025-03-24 | 227853 |
SANDOZ TIMOLOL | SANDOZ CANADA INCORPORATED | Actual shortage | 0.5% | Updated Report | 2025-03-24 | 252713 |
SANDOZ TIMOLOL | SANDOZ CANADA INCORPORATED | Actual shortage | 0.25% | Updated Report | 2025-03-24 | 249432 |
SANDOZ SILODOSIN | SANDOZ CANADA INCORPORATED | Actual shortage | 8MG | Updated Report | 2025-03-24 | 244446 |
SANDOZ RIVASTIGMINE PATCH 10 | SANDOZ CANADA INCORPORATED | Actual shortage | 9.5MG | Updated Report | 2025-03-24 | 252700 |
PMS-OXYBUTYNIN | PHARMASCIENCE INC | Resolved | 5MG | Updated Report | 2025-03-24 | 248010 |
SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD | SANDOZ CANADA INCORPORATED | Actual shortage | 2.5MG 8MG | Updated Report | 2025-03-24 | 250519 |
SANDOZ LOSARTAN HCT | SANDOZ CANADA INCORPORATED | Actual shortage | 12.5MG 50MG | Updated Report | 2025-03-24 | 248645 |
SANDOZ LOSARTAN HCT | SANDOZ CANADA INCORPORATED | Actual shortage | 12.5MG 100MG | Updated Report | 2025-03-24 | 251581 |
SANDOZ LISDEXAMFETAMINE CAPSULES | SANDOZ CANADA INCORPORATED | Actual shortage | 40MG | Updated Report | 2025-03-24 | 251578 |
SANDOZ LACOSAMIDE | SANDOZ CANADA INCORPORATED | Actual shortage | 150MG | Updated Report | 2025-03-24 | 252692 |
FUROSEMIDE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Actual shortage | 10MG | Updated Report | 2025-03-24 | 248629 |
SANDOZ DEFERASIROX (TYPE J) | SANDOZ CANADA INCORPORATED | Actual shortage | 180MG | Updated Report | 2025-03-24 | 247593 |
METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Actual shortage | 25MG | Updated Report | 2025-03-24 | 239730 |
DEFEROXAMINE MESYLATE FOR INJECTION | PFIZER CANADA ULC | Actual shortage | 500MG | Updated Report | 2025-03-24 | 243095 |
!!T3 MARCAINE E | PFIZER CANADA ULC | Actual shortage | 0.182MG 50MG | Updated Report | 2025-03-24 | 207832 |
SANDOZ TELMISARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 40MG | Updated Report | 2025-03-24 | 252710 |
SANDOZ LOSARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 25MG | Updated Report | 2025-03-24 | 251116 |
SANDOZ LISINOPRIL HCT | SANDOZ CANADA INCORPORATED | Actual shortage | 25MG 20MG | Updated Report | 2025-03-24 | 218465 |
SANDOZ FENOFIBRATE E | SANDOZ CANADA INCORPORATED | Actual shortage | 48.0MG | Updated Report | 2025-03-24 | 252689 |
SANDOZ FENOFIBRATE E | SANDOZ CANADA INCORPORATED | Actual shortage | 145.0MG | Updated Report | 2025-03-24 | 252686 |
SANDOZ ESOMEPRAZOLE | SANDOZ CANADA INCORPORATED | Actual shortage | 40MG | Updated Report | 2025-03-24 | 251562 |
NEUPOGEN | AMGEN CANADA INC | Actual shortage | 300MCG | Updated Report | 2025-03-24 | 250477 |
TRUSOPT | ELVIUM LIFE SCIENCES | Resolved | 2% | Updated Report | 2025-03-22 | 252634 |
TIMOPTIC-XE | ELVIUM LIFE SCIENCES | Resolved | 0.5% | Updated Report | 2025-03-22 | 252828 |
LISINOPRIL | SIVEM PHARMACEUTICALS ULC | Actual shortage | 5MG | Updated Report | 2025-03-22 | 250137 |
GENOTROPIN | PFIZER CANADA ULC | Resolved | 1.6MG | Updated Report | 2025-03-22 | 201511 |
CLARITHROMYCIN | SIVEM PHARMACEUTICALS ULC | Actual shortage | 250MG | Updated Report | 2025-03-22 | 250134 |
COSOPT | ELVIUM LIFE SCIENCES | Resolved | 5MG 20MG | Updated Report | 2025-03-22 | 253012 |
ACH-LEVETIRACETAM | ACCORD HEALTHCARE INC | Actual shortage | 250MG | Updated Report | 2025-03-22 | 253221 |
VENTOLIN DISKUS | GLAXOSMITHKLINE INC | Anticipated shortage | 200MCG | Updated Report | 2025-03-21 | 252627 |
IMITREX | GLAXOSMITHKLINE INC | Resolved | 20MG | Updated Report | 2025-03-21 | 252843 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | HIKMA CANADA LIMITED | To be discontinued | 0.2% | New Report | 2025-03-24 | 253342 |
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | HIKMA CANADA LIMITED | To be discontinued | 0.2% | New Report | 2025-03-24 | 253339 |
LATANOPROST OPHTHALMIC SOLUTION | HIKMA CANADA LIMITED | To be discontinued | 50MCG | New Report | 2025-03-24 | 253336 |
TEVA-FINGOLIMOD | TEVA CANADA LIMITED | Discontinued | 0.5MG | New Report | 2025-03-20 | 253186 |
TEVA-PAROXETINE | TEVA CANADA LIMITED | Discontinued | 10MG | New Report | 2025-03-20 | 253182 |